key: cord-0809762-dpizxbt4
authors: Pandit, Kamal; Kc, Kripa; Khanal, Sushil; Thapa, Sanjay Raj; Shah, Chiranjiwi Prasad; Pokharel, Ritisha; Adhikari, Prabhat
title: Coronavirus disease 2019 (COVID 19) induced acute necrotizing pancreatitis in a female child: A case report
date: 2022-03-29
journal: Ann Med Surg (Lond)
DOI: 10.1016/j.amsu.2022.103551
sha: 5722838055f53e28d5a8ea47bf7d2cffcf0e1b71
doc_id: 809762
cord_uid: dpizxbt4

nan

Coronavirus disease 2019 (COVID 19) has been noticed to infect different organ systems including the respiratory, gastrointestinal and cardiovascular system. Fever, cough, sore throat, dyspnea, headache and myalgia are most common manifestations of COVID 19 infection [1] . When the gastrointestinal system is involved, anorexia, nausea, vomiting, abdominal pain, and diarrhea are common presenting symptoms. Pancreatic involvement in COVID 19 infection is very uncommon and has rarely been reported in literature. It is postulated that expression of Angiotensin-Converting Enzyme 2 (ACE2) receptors in the pancreatic cell is responsible for pancreatic involvement [2] . Glycosylated-spike (S) protein in corona virus binds to ACE2 receptors in the pancreas leading to acute pancreatitis [3] . Here, we present a case of acute pancreatitis in a 12 years old female child with COVID 19.

A 12 years old female presented to the emergency department with the chief complaints of fever, dry cough, lethargy and shortness of breath for four days. The patient also had multiple episodes of vomiting which was associated with epigastric pain which was sudden in onset, progressive in nature with no aggravating and relieving factors. She had no significant past medical and surgical history. She was not taking any regular medications.

On presentation to emergency department, she was alert and oriented. Her Glasgow Coma Scale (GCS) was 15/15.Her initial evaluation revealed a temperature of 99°F, a blood pressure of 110/70 mmHg, a heart rate of 98 beats per minute, a respiratory rate of 24 per minute, and an oxygen saturation of 88% in room air. Chest examination revealed decreased air entry in bilateral axillary region with occasional crepitations. Abdominal examination revealed mild epigastric tenderness.

Otherwise, the rest of the physical exam was non-significant. She was admitted to the intensive care unit and was managed symptomatically intravenous fluids, and analgesics. Intravenous dexamethasone and subcutaneous low molecular weight heparin (LMWH) was given as per COVID protocol. She was started on high-flow oxygen supplementation for hypoxic respiratory failure. Her temperature subsided gradually. Oxygen requirement declined over the next 12 days with gradual improvement in her pulmonary and gastrointestinal symptoms and she was discharged. The patient was asymptomatic on 14th day follow-up.

More than half of the patient with COVID 19 infection develops gastrointestinal symptoms such as nausea, vomiting, diarrhea and abdominal pain; diarrhea being the most common symptom in adults whereas vomiting is found to be more prominent in children. However, pancreatic involvement is very rare and in pediatric population it is even rarer [4] . A study done by Fan Wang has shown that nine out of 52 patients with COVID 19 infection have pancreatic injury [5] .

Furthermore, approximately 10 % of the COVID 19 positive patients may present only with gastrointestinal symptoms [6] .

Pancreatitis has been classified based on organ involvement and duration. Clinical presentation of the patient, laboratory values and the imaging modalities are used to diagnose the acute pancreatitis. Two of the following three criteria must be met to diagnose acute pancreatitis: (1) upper abdominal pain (acute in onset, epigastric area radiating to back) (2) serum lipase or amylase level >three times the upper limit of normal value (3) acute pancreatitis findings on imaging modalities (such as ultrasonography, abdominal CT or magnetic resonance imaging (MRI)) [7] . In our case, the lipase and amylase were not high, possibly due to the necrosed pancreas. Once the diagnosis is made, acute pancreatitis is managed symptomatically with supportive care with intravenous fluid and analgesics [8] .

The association of pancreatitis with various viral infections is well known. With ongoing COVID-19 pandemic, the association of this disease with acute pancreatitis has been reported as well. The exact pathophysiology of acute pancreatitis in corona virus disease is still exactly not known.

However, Angiotensin receptor-converting enzyme-2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) has been linked to the pathogenesis of acute pancreatitis in corona virus disease [9] .

ACE2 expression is usually found in pancreatic islets, exocrine gland and ductal cells while TMPRSS2 is mainly expressed in ductal cells [10] . S glycoprotein which is found in cell surface of the virus binds to ACE2 on surface of host cell leading to entry into the host cell and this process is facilitated by TMPRSS2 [5] . Since these proteins are highly expressed in pancreatic islets, exocrine and ductal cells, it is believed to be behind the pathogenesis of acute pancreatitis.

Acute pancreatitis is notorious to cause inflammation in surrounding areas such as arteries and veins in addition to the pancreas itself. The vessels near the inflamed pancreas undergo inflammatory changes altering the coagulation factor which may result in thrombosis as seen in the splenic vein of our patient. The occurrence of such vascular complications has been reported to be up to 57% in cases of acute necrotizing pancreatitis [11] .

Many cases of COVID 19 disease with acute pancreatitis have been reported in the literature. A case report by Gonzalo-Voltas et al from Spain included a 76 years female with acute pancreatitis in COVID 19 disease without the evidence of gallstones and alcohol [12] . Our patient was healthy, with no family history of any pancreatic disease and had no any evidence of gallstone. The serum triglyceride level of 209 mg/dl is less likely to be a possible cause of pancreatitis in this case. The improvement in her condition with conservative management along with positive PCR for COVID 19 confirmed acute necrotizing pancreatitis attributable to COVID 19. However, this corona virus still remains an enigma to all of us with varying clinical presentation and findings and more research is required to link COVID 19 with pancreatitis. To our knowledge, this may be the pioneer reported case of COVID 19 induced acute necrotizing pancreatitis in the pediatric age group. This case report has been reported in line with the SCARE 2020 criteria [13] .

The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China

Global patterns in coronavirus diversity

Epidemiology, genetic recombination, and pathogenesis of coronaviruses

gastrointestinal features in COVID-19 and the possibility of faecal transmission

Pancreatic Injury Patterns in Patients With Coronavirus Disease 19 Pneumonia

Acute pancreatitis and COVID-19: A literature review

American College of Gastroenterology guideline: management of acute pancreatitis

Acute pancreatitis: update on management

COVID-19 Presenting as Acute Necrotizing Pancreatitis

SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 Are Expressed in the Microvasculature and Ducts of Human Pancreas but Are Not Enriched in β Cells

Vascular complications in acute pancreatitis assessed by color duplex ultrasonography

Acute pancreatitis in a patient with COVID-19 infection

Name of the registry: Not applicable 2. Unique Identifying number or registration ID: 3. Hyperlink to your specific registration

J o u r n a l P r e -p r o o f Highlights:1. Although Coronovirus disease 2019 mainly affects respiratory symptoms, the involvement of gastrointestinal system is also quite common. 2. The precise mechanism by which the virus causes pancreatitis is not well understood. 3 . Coronavirus disease should be ruled out in cases of pancreatitis when the etiology is not found out.J o u r n a l P r e -p r o o f

The following information is required for submission. Please note that failure to respond to these questions/statements will mean your submission will be returned. If you have nothing to declare in any of these categories then this should be stated.

All authors must disclose any financial and personal relationships with other people or organisations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding.No any conflicts of interest.

All sources of funding should be declared as an acknowledgement at the end of the text. Authors should declare the role of study sponsors, if any, in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication. If the study sponsors had no such involvement, the authors should so state.This study has not received any funding.

Research studies involving patients require ethical approval. Please state whether approval has been given, name the relevant ethics committee and the state the reference number for their judgement.This study was conducted in accordance with ethical standard..

Studies on patients or volunteers require ethics committee approval and fully informed written consent which should be documented in the paper.Authors must obtain written and signed consent to publish a case report from the patient (or, where applicable, the patient's guardian or next of kin) prior to submission. We ask Authors to confirm as part of the submission process that such consent has been obtained, and the manuscript must include a statement to this effect in a consent section at the end of the manuscript, as follows: "Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request".Patients have a right to privacy. Patients' and volunteers' names, initials, or hospital numbers should not be used. Images of patients or volunteers should not be used unless the information is essential for scientific purposes and explicit permission has been given as part of the consent. If such consent is made subject to any conditions,the Editor in Chiefmust be made aware of all such conditions.Even where consent has been given, identifying details should be omitted if they are not essential. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note.Written informed consent was obtained from the patient`s parent for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.

Please specify the contribution of each author to the paper, e.g. study concept or design, data collection, data analysis or interpretation, writing the paper, others, who have contributed in other ways should be listed as contributors.I. Kamal Pandit worked for literature review, discussion of the case report and revision of the case report into its final version. II.Kripa KC took the relevant history, clinical examination, collected relevant investigations of the patient and wrote the report. III.Sushil Khanal helped in the revision of the case report into its final version IV.Sanjay Raj Thapa Thapa helped in the revision of the case report into its final version.He was directly involved in patient's management in the hospital. V.Ritisha Pokharel ,Chiranjiwi Prasad Shah and Prabhat Adhikari also wrote the case report helped in the revision of the case report into its final version.J o u r n a l P r e -p r o o f

In accordance with the Declaration of Helsinki 2013, all research involving human participants has to be registered in a publicly accessible database. Please enter the name of the registry and the unique identifying number (UIN) of your study.